Merit Medical Systems MMSI Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 48.7%+0.9pp | 48.7%+1.3pp | 48.5%+1.6pp | 47.9%+1.4pp | 47.8%+1.3pp | |
| Operating margin | 12.2%+0.6pp | 12.2%+0.7pp | 11.3%-0.2pp | 11.3%-0.3pp | 11.6%+1.2pp | |
| Net margin | 9%+0.2pp | 8.5%-0.4pp | 8%-1.0pp | 8.3%-0.7pp | 8.8%+0.9pp | |
| EBITDA margin | 20.2%+0.9pp | 20.3%+1.3pp | 19.5%+0.6pp | 19.3%+0.4pp | 19.4%+1.7pp | |
| Free cash flow margin | 14.3%+1.3pp | 14.2%+0.5pp | 14%+0.8pp | 13.4%-0.4pp | 13%+2.6pp | |
| Returns | ||||||
| Return on equity | 9.1%0.0pp | 8.7%-0.7pp | 8.3%-1.1pp | 8.6%-0.8pp | 9.2%+0.7pp | |
| Return on assets | 5.4%+0.3pp | 5%0.0pp | 4.7%-1.0pp | 4.8%-0.8pp | 5.1%0.0pp | |
| Return on invested capital | 7.4%-0.2pp | 7.4%-0.2pp | 7.2%-0.6pp | 7.3%-0.8pp | 7.6%-0.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×-0.1× | |
| Inventory turnover | 2.4×0.0× | 2.4×+0.1× | 2.4×+0.1× | 2.4×+0.1× | 2.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 5.1×+0.2× | 4.3×+0.1× | 4.3×-1.1× | 4.1×-2.2× | 4.9×-1.2× | |
| Quick ratio | 3.5×+0.2× | 2.9×+0.1× | 2.9×-1.0× | 2.7×-2.0× | 3.3×-1.1× | |
| Cash ratio | 2.3×+0.2× | 1.9×+0.1× | 1.7×-0.9× | 1.5×-1.9× | 2×-1.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×-0.1× | 0.5×-0.1× | 0.5×-0.1× | 0.6×-0.1× | 0.6×-0.1× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Net debt / EBITDA | 1.1×-0.5× | 1.2×-0.4× | 1.5×+0.3× | 1.7×+0.8× | 1.6×+0.3× | |
| Interest coverage | 7.1×+1.7× | 7×+2.0× | 5.9×+0.5× | 5.6×-0.3× | 5.4×-0.8× | |
| Per Share | ||||||
| Book value per share | $27.11+16.3% | $26.20+12.8% | $25.52+14.8% | $24.55+12.5% | $23.31+10.1% | |
| Valuation | ||||||
| Market capitalization | $4.1B-34.1% | $5.23B-7.3% | $4.93B-14.2% | $5.51B+10.3% | $6.22B+41.7% | |
| Enterprise value | $4.43B-33.3% | $5.6B-7.5% | $5.36B-11.3% | $5.99B+14.5% | $6.64B+41.9% | |
| Price / earnings | 29.4×-21.5× | 40.7×-6.2× | 41.6×-6.2× | 46.3×+3.7× | 50.9×+7.8× | |
| Price / sales | 2.7×-1.8× | 3.4×-0.7× | 3.3×-1.0× | 3.8×0.0× | 4.5×+1.1× | |
| Price / book | 2.5×-1.8× | 3.3×-0.8× | 3.2×-1.1× | 3.7×-0.2× | 4.4×+0.8× | |
| EV / EBITDA | 14.2×-10.5× | 18.2×-5.2× | 18.6×-5.5× | 21.6×+0.4× | 24.7×+4.0× | |
| EV / sales | 2.9×-1.9× | 3.7×-0.8× | 3.6×-0.9× | 4.2×+0.2× | 4.8×+1.1× | |
| Free cash flow yield | 5.4%+2.5pp | 4.1%+0.8pp | 4.2%+1.1pp | 3.5%-0.1pp | 2.9%-0.1pp | |
| Earnings yield | 3.4%+1.4pp | 2.5%+0.3pp | 2.4%+0.3pp | 2.2%-0.2pp | 2%-0.4pp | |
| PEG ratio | 2.1×-0.4× | 6×+4.3× | —— | 32.2×+30.8× | 2.6×+0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Merit Medical Systems's profit margins?
- Merit Medical Systems (MMSI) runs a 48.7% gross margin and a 12.2% operating margin, with a 9.0% net margin.
- Where do Merit Medical Systems's ratios come from?
- Every ratio is computed from Merit Medical Systems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.